| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.28B | 31.95B | 29.77B | 28.99B | 26.96B | 22.66B |
| Gross Profit | 15.17B | 15.37B | 14.44B | 13.95B | 12.66B | 10.69B |
| EBITDA | 5.30B | 5.37B | 4.97B | 5.67B | 5.04B | 3.86B |
| Net Income | 2.28B | 2.33B | 2.08B | 2.49B | 2.26B | 1.46B |
Balance Sheet | ||||||
| Total Assets | 37.04B | 37.31B | 34.66B | 34.00B | 31.01B | 28.35B |
| Cash, Cash Equivalents and Short-Term Investments | 5.62B | 5.38B | 4.94B | 4.06B | 3.61B | 3.65B |
| Total Debt | 11.32B | 9.17B | 11.39B | 12.65B | 12.13B | 12.49B |
| Total Liabilities | 18.88B | 17.35B | 17.56B | 19.13B | 19.06B | 19.25B |
| Stockholders Equity | 17.03B | 18.81B | 15.95B | 13.89B | 11.03B | 8.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.51B | 3.28B | 1.27B | 1.01B | 3.20B |
| Operating Cash Flow | 0.00 | 4.90B | 3.76B | 1.79B | 1.42B | 3.60B |
| Investing Cash Flow | 0.00 | -1.25B | -555.00M | -585.00M | -569.00M | 221.00M |
| Financing Cash Flow | 0.00 | -3.33B | -2.48B | -1.05B | -1.03B | -3.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥43.46B | 9.64 | ― | 2.86% | 6.10% | 19.77% | |
78 Outperform | ¥29.10B | 9.99 | ― | 3.82% | 8.69% | 18.95% | |
65 Neutral | ¥94.45B | 21.35 | ― | 3.41% | 5.24% | -71.41% | |
65 Neutral | ¥82.42B | 11.45 | ― | 2.35% | 11.86% | 207.24% | |
64 Neutral | ¥28.73B | 13.39 | ― | 4.27% | 2.37% | -16.75% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥18.99B | 15.81 | ― | 1.93% | 4.76% | -17.51% |